This analysis demonstrated a significant upregulation of both IER2 and OPN protein expression in primary melanomas, compared to MN, and further upregulation of OPN in distant metastases (Fig. 8b, for clinicopathological data, see Table S4). The gene discussed is IER2; the disease is melanoma.